Breaking Gene Therapy News
-
FDA Approves First Gene Therapy for Hemophilia B - Consultant360
Nov 28, 2022 | 19:47 pmFDA Approves First Gene Therapy for Hemophilia B Consultant360
Read more... -
Potential Modifier Gene Therapy for Degenerative Retinal Diseases - FierceBiotech
Nov 28, 2022 | 18:53 pmPotential Modifier Gene Therapy for Degenerative Retinal Diseases FierceBiotech
Read more... -
FDA grants speedy review to Sarepta's Duchenne gene therapy - BioPharma Dive
Nov 28, 2022 | 17:53 pmFDA grants speedy review to Sarepta's Duchenne gene therapy BioPharma Dive
Read more... -
Breaking barriers to gene therapies for childhood rare diseases - Labiotech.eu
Nov 28, 2022 | 17:05 pmBreaking barriers to gene therapies for childhood rare diseases Labiotech.eu
Read more... -
Genentech starts phase 2 trial to optimize cell therapy delivery - FiercePharma
Nov 28, 2022 | 16:20 pmGenentech starts phase 2 trial to optimize cell therapy delivery FiercePharma
Read more... -
Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy - Yahoo Finance
Nov 28, 2022 | 14:30 pmTenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy Yahoo Finance
Read more... -
Mainstreaming cell and gene therapy – Realizing its potential - BioPharma Dive
Nov 28, 2022 | 11:11 amMainstreaming cell and gene therapy – Realizing its potential BioPharma Dive
Read more... -
Big Pharma's Twitter exodus; Merck wagers $1.35B on buyout; $3.5M gene therapy; and more - Endpoints News
Nov 26, 2022 | 12:00 pmBig Pharma's Twitter exodus; Merck wagers $1.35B on buyout; $3.5M gene therapy; and more Endpoints News
Read more... -
Current Research and Logistical Considerations for Gene Therapy in Hemophilia - AJMC.com Managed Markets Network
Nov 25, 2022 | 17:26 pmCurrent Research and Logistical Considerations for Gene Therapy in Hemophilia AJMC.com Managed Markets Network
Read more... -
Measuring Potency of Cell and Gene Therapy Products - Technology Networks
Nov 25, 2022 | 01:00 amMeasuring Potency of Cell and Gene Therapy Products Technology Networks
Read more... -
FDA Adcomm Cancels Meeting on BioMarin's Hemophilia A Gene Therapy - BioSpace
Nov 23, 2022 | 19:45 pmFDA Adcomm Cancels Meeting on BioMarin's Hemophilia A Gene Therapy BioSpace
Read more... -
Combining gene therapy and medical device makes progress in RP - Ophthalmology Times
Nov 23, 2022 | 13:00 pmCombining gene therapy and medical device makes progress in RP Ophthalmology Times
Read more... -
FDA approves a gene therapy for hemophilia B - STAT
Nov 22, 2022 | 22:22 pmFDA approves a gene therapy for hemophilia B STAT
Read more... -
Replay reveals second gene therapy spinout, debuting new biotech Telaria - BioPharma Dive
Nov 21, 2022 | 17:58 pmReplay reveals second gene therapy spinout, debuting new biotech Telaria BioPharma Dive
Read more... -
Gene Therapy Briefs: Cure Rare Disease CEO's Brother Died in Clinical Trial - Genetic Engineering & Biotechnology News
Nov 21, 2022 | 12:26 pmGene Therapy Briefs: Cure Rare Disease CEO's Brother Died in Clinical Trial Genetic Engineering & Biotechnology News
Read more... -
Gene Therapy Myth Busting - Pfizer
Nov 18, 2022 | 22:41 pmGene Therapy Myth Busting Pfizer
Read more... -
Lysogene's lead gene therapy fails phase 2/3 trial with cash low - FierceBiotech
Nov 18, 2022 | 21:44 pmLysogene's lead gene therapy fails phase 2/3 trial with cash low FierceBiotech
Read more... -
Gene Therapy for Hemophilia Is on the Brink of FDA Approval - Managed Healthcare Executive
Nov 17, 2022 | 09:00 amGene Therapy for Hemophilia Is on the Brink of FDA Approval Managed Healthcare Executive
Read more... -
Seize the Day: Activity-Dependent Gene Therapy Shows Promise to Treat Epilepsy and Brain Circuit Disorders - Genetic Engineering & Biotechnology News
Nov 3, 2022 | 08:00 amSeize the Day: Activity-Dependent Gene Therapy Shows Promise to Treat Epilepsy and Brain Circuit Disorders Genetic Engineering & Biotechnology News
Read more... -
Proof-of-concept study advances potential new way to deliver gene therapy - Ophthalmology Times
Nov 2, 2022 | 08:00 amProof-of-concept study advances potential new way to deliver gene therapy Ophthalmology Times
Read more...